News
Skin reactions common at insulin pump infusion sites
- Author:
- Miriam E. Tucker
The inflammatory response “may result in tissue changes responsible for the infusion-site failures seen frequently in clinical practice,” say the...
News
Kombucha benefits type 2 diabetes, study suggests
- Author:
- Miriam E. Tucker
“Kombucha is a growing part of the beverage market in the United States and the world.”
News
New approaches for diabetic keratopathy in the eye?
- Author:
- Miriam E. Tucker
“Our goal is to develop topical, sustained-release drugs for corneal wound healing.”
News
New guidelines on diabetes-related laboratory testing
- Author:
- Miriam E. Tucker
“We do a lot of testing in screening, diagnosis, and monitoring of diabetes and its complications, yet for many clinicians we think that any...
Opinion
Debate: Initial combination therapy for type 2 diabetes?
- Author:
- Miriam E. Tucker
Ralph A. DeFronzo, MD, argued for combination therapy at the time of diagnosis, and David M. Nathan, MD, countered that sequential therapy is a...
News
FDA clears the Tandem Mobi insulin pump
- Author:
- Miriam E. Tucker
The device is approved for people with diabetes aged 6 years and up.
News
Aging and type 1 diabetes: ‘Complete picture’ 40 years on
- Author:
- Miriam E. Tucker
“The EDIC study is now shifting its focus during the next 5 years to understand the clinical course of type 1 diabetes in the setting of advancing...
News
COORDINATE-Diabetes: A ‘wake-up call’ for many specialties
- Author:
- Miriam E. Tucker
“I look at COORDINATE as a wake-up call to the need for multispecialty approaches to people with type 2 diabetes and cardiovascular disease.”
News
Thirty-three percent of type 1 diabetes patients insulin free with stem cells
- Author:
- Miriam E. Tucker
Engraftment of Vertex Pharmaceutical’s VX-880 stem cell–derived islets has now been achieved in six patients, two of whom are insulin-independent...
News
FDA OKs pancreatic islet cell therapy for type 1 diabetes
- Author:
- Miriam E. Tucker
“Today’s approval ... provides individuals living with type 1 diabetes and recurrent severe hypoglycemia an additional treatment option to help...
News
Once-weekly basal insulin nears market for type 2 diabetes
- Author:
- Miriam E. Tucker
“I feel that weekly insulins have the potential to become transformational as preferred options for basal insulin replacement in people with type...
News
ADA: Screen all with type 2 diabetes for fatty liver disease
- Author:
- Miriam E. Tucker
The ADA now advises screening all adults with type 2 diabetes or prediabetes, particularly those with obesity or cardiometabolic risk factors or...
News
Surgery, radioactive iodine for hyperthyroidism up survival
- Author:
- Miriam E. Tucker
“I think this is something we need to take into our discussions with patients because treatment for hyperthyroidism is very much individualized...
News
Scripts surge for desiccated thyroid extract to treat hypothyroidism
- Author:
- Miriam E. Tucker
Among first-time thyroid hormone prescriptions, those for DTE rose from 5.4% in 2010 to 10.2% in 2020.
News
FDA OKs empagliflozin for children with type 2 diabetes
- Author:
- Miriam E. Tucker
This approval represents only the second oral treatment option for children and adolescents with type 2 diabetes after metformin.